Dietary effects on nontraditional risk factors for heart disease by NC DOCKS at Appalachian State University & Root, Martin
Archived version from NCDOCKS Institutional Repository http://libres.uncg.edu/ir/asu/ 
Dietary effects on nontraditional risk 
factors for heart disease
Authors: Martin Root, John J.B. Anderson
Abstract Diet has long been known to play a key role in modifying the major risk factors for heart 
disease, namely, dyslipidemia and hypertension. Numerous recent advances have suggested that 
dietary components, particularly those in a traditional Mediterranean diet, may also improve 
nontraditional risk factors. Fish and fish n-3 fatty acids reduce the risk of cardiac arrhythmias. 
The monounsaturated fatty acids in olive oil may inhibit and reverse the clotting process. The 
phytochemicals in fruits and vegetables may reduce both inflammation and clotting. Alcohol, 
usually in the form of red wine, may lower inflammation and improves endothelial function. The 
traditional Mediterranean diet is low in processed foods containing trans fatty acids and high 
glycemic index ingredients which increase inflammation and raise lipoprotein (a). The combined 
effects of these foods has been shown to reduce significantly the risk of heart disease.
Martin Root, John J.B. Anderson(2004)Dietary effects on 
nontraditional risk factors for heart disease.  Nutrition 
Research [doi:10.1016] (ISSN 0271-5317)
Dietary effects on nontraditional risk factors for heart 
disease 
Martin Root, John J.B. Anderson
Abstract 
Diet has long been known to play a key role in modifying the major risk factors for heart disease, 
namely, dyslipidemia and hypertension. Numerous recent advances have suggested that dietary 
components, particularly those in a traditional Mediterranean diet, may also improve nontraditional 
risk factors. Fish and fish n-3 fatty acids reduce the risk of cardiac arrhythmias. The monounsaturated 
fatty acids in olive oil may inhibit and reverse the clotting process. The phytochemicals in fruits and 
vegetables may reduce both inflammation and clotting. Alcohol, usually in the form of red wine, may 
lower inflammation and improves endothelial function. The traditional Mediterranean diet is low in 
processed foods containing trans fatty acids and high glycemic index ingredients which increase 
inflammation and raise lipoprotein (a). The combined effects of these foods has been shown to reduce 
significantly the risk of heart disease. 
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1. Introduction
The major risk factors of coronary heart disease (CHD), known for many decades, include
dyslipidemia, hypertension, smoking, and diabetes. Drugs that reduce LDL cholesterol or 
lower blood pressure help reduce the burden of this disease. More recently, additional risk 
factors have been elucidated  that suggest new pathologic mechanisms at work in  the 
causation of CHD. 
Dietary intervention has always been an important instrument for ameliorating heart 
disease. The American Heart Association has developed recommended interventional diets. 
Beginning the 1960s new dietary information has affected food consumption patterns in 
economically developed countries and may be responsible, in part, for the reduction in CHD. 
However, as the Study showed, large differences exist between the CHD incidence rates 
among countries that are not explained by the major risk factors [1]. 
2. Diet and CHD in Mediterranean countries
The countries along the Mediterranean coast (in particular Spain, southern France, Italy,
and Greece) have lower rates of CHD than would be expected from the average major risk 
factors found in those countries. The diets in these areas have been credited by many for these 
effects (Table 1). Of course, considerable variety exists in the diets of these countries; 
however, compared to the average diet in the United States (Table 1) several common factors 
have attracted attention (Table 2). Olive oil consumption is particularly high across this 
region. Limited red meat and moderate fish consumption is common. Fruit and vegetable 
consumption is high. Moderate alcohol intake, especially wine with meals, is common. 
Staples include legumes, rice, and pasta. Dairy products are available but are not consumed in 
large amounts. 
The Lyon Diet Heart Study used a slightly modified Mediterranean diet for the treatment of 
302 patients with CHD. This diet reduced subsequent heart attacks by 72% over 3.8 years [2]. 
In addition, the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico 
Table 1 
Comparison of typical northern European and North American diet with common elements of a traditional 
Mediterranean diet 
Dietary elements European-American diet Traditional Mediterranean diet 
Fats Saturated and n-6 fatty acid-rich vegetable oils Olive oil 
Meat High in red meat, also poultry, low fish Low in red meat and more poultry, 
moderate (and variable) fish 
Legumes and nuts Some peanuts, low in nuts and dried beans Beans, nuts, seeds 
Grains Refined flour in breads, many sweets More pasta and bread, and less 
sweets 
Fruits and vegetables Low to moderate consumption Moderate to high consumption of 
green vegetables, roots, and fresh 
fruit 
Dietary fiber Low Moderate to high 
Alcohol Low and variable Wine with meals 
Processed foods High, including baked products and snacks Low, with fresh fruits and vegetables, 
whole grains and legumes 
Dairy foods Milk, cheese, ice cream Less milk and ice cream, moderate 
cheese 
Table 2 
Summary of the effects of a Mediterranean diet and additional factors on non-traditional risk factors of heart 
disease 
Feature of diet More or less in 
Mediterranean diet 
Active component Risk factor effects 
Beneficial factors 
Fish More Long chain n-3 
polyunsaturated 
fatty acids 
Olive oil and nuts More Monounsaturated 
fatty acids 
Fruit and vegetables and garlic More Phytochemical, 
vitamins, and 
fiber 
 cardiac arrhythmia  
platelet aggregation 
FMV 
 lipoprotein (a) 
     inflammation 
 platelet aggregation 
  fibrinolysis  
  FMV 
        Platelet 
aggregation  
fibrinolysis  
      antioxidants 
CRP  
Fibrinogen   
Homocysteine 
FMV 
Red wine More Alcohol platelet aggregation 
Fibrinolysis  
bleeding  time   
CRP   
  FMV   
Adverse factors 
Processed foods and snacks Less Trans and 
saturated 
fatty acids, 
high–glycemic 
index  foods 
CRP 
zlipoprotein (a) 
  FMV 
Other factors 
Obesity    CRP 
 FMV 
Exercise  CRP 
FMV 
Antioxidant vitamin supplements no effect 
B-vitamin supplements folate, vitamins B6
and B12
A homocysteine 
CRP = C-reactive protein; FMV = flow-mediated vasodilation. 
(GISSI-Prevenzione) trial gave general dietary advice toward a Mediterranean-style diet to 
11,323 CHD patients. Researchers found that the quartile of subjects who most closely 
followed the dietary advice had a 49% reduction in the odds of subsequent death [3]. These 
and similar studies emphasize an entire food pattern, as opposed to one or another specific 
nutrient, that is effective in reducing the risk of CHD. 
 
 
3. Mechanism of action of components of the Mediterranean diet 
The Lyon and GISSI studies are most interesting in that little or no effect of the diets was 
observed on the traditional risk factors of blood pressure and serum lipids. Therefore, the 
effects of these dietary components must be acting through other pathological pathways 
involved in CHD. These other components of diet and their mechanisms are the subject of 
this review. Possible mechanisms involved in CHD include the clotting process, the systemic 
inflammatory response, cardiac arrhythmias, and endothelial function. Dietary components 
that affect these pathways include fish and the n-3 fatty acids, olive oil and the 
monounsaturated fatty acids (MUFA), the lack of trans fatty acids, various phytochemicals 
and antioxidants, and moderate alcohol consumption. 
Each of the above mechanisms is complex, consisting of a unique set of pathways, 
cascades, inhibitors, biomarkers, and local and systemic effects and interactions. Since CHD 
is largely a vascular disease and blood is a readily available material, numerous biomarkers of 
various pathways have been postulated. However, only a few have been shown to be 
significantly predictive of cardiac events in clinical and epidemiological studies. These other 
mechanisms have also been studied in biological systems not directly connected to their 
vascular effects in humans. Information about the complex pathways has been established in 
cell culture and animal studies, and with ex vivo and in vitro measurements. Although 
nutrient effects may be measured in these systems, the relevance to the chronic human 
condition of atherosclerotic CHD is often a leap of faith. This review also assesses the 
relevance of these findings in the light of observed dietary effects on CHD. 
 
4. Inflammation 
Ross and Glomset in 1973 first identified inflammation as a cause of atherosclerosis [4]. 
Although much is known about the process of inflammation, only a few biomarkers have 
been correlated directly with CHD. C-reactive protein (CRP) has gained considerable 
currency as a new risk factor for heart disease in the last few years [5] and has led to a 
renewed interest in the role of systemic inflammation in heart disease. 
Many of the phytochemicals in fruits and vegetables have strong antioxidant properties 
that have been implicated through their effects on cell and animal model systems. However, 
when the major nutrient antioxidants, a-tocopherol, vitamin C, and h-carotene, have been 
tested in purified forms in clinical trials, they have been found to be ineffective in preventing 
actual coronary events [6]. Thus, the direct actions of pro-oxidants and free radicals on the 
atherosclerotic process have been cast in some doubt. These putative direct actions, as 
measured in model systems, include the oxidation of LDL and the production of 
malondialdehyde-derived products. 
Pro-oxidants may have more powerful biological effects indirectly through the 
inflammatory process [7]. Nuclear factor–nB (NFnB) is a critical messenger in initiating 
inflammation. Reactive oxygen species play a key role in releasing cytoplasmic NFjB for 
translocation to the nucleus and activation of the transcription of genes for numerous 
cytokines, growth factors, and adhesion molecules. Dietary antioxidants may have a limited 
role  in  reducing  inflammation  through  reduction  of  reactive  oxygen  species  and  the 
 
 
inactivation of NFnB. For example, g-tocopherol has also been shown to decrease the release 
and activation of NFnB [8]. 
The n-3 fatty acids, a-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid, 
being highly unsaturated, have mixed effects of the oxidant/antioxidant pathways and 
markers. However, they have been shown to affect a fairly consistent suppression of the 
inflammatory response. It has been hypothesized that this suppression is through the 
production of n-3 derived eicosanoids, that displace eicosanoids derived from the n-6 fatty 
acid arachidonic acid, the primary substrate of eicosanoid synthesis [9]. There is a reduction 
in the more inflammatory n-6 derived leukotriene B4 and an increase in n-3 derived 
leukotriene B5, a weaker inducer of inflammation. Supplementation with n-3 fatty acids has 
also been shown to reduce the expression of pro-inflammatory cytokine IL-1 [10]. Intake of 
trans fatty acids has been positively associated with systemic inflammatory markers in 
healthy women [11]. 
The acute phase response, as exemplified by the rise in serum CRP, has come under 
renewed interest since the mid 1990s when, using a newer high sensitivity assay, it was 
discovered that small increases in baseline CRP indicate increased risk for CHD [12]. CRP 
levels are positively correlated with many of the known risk factors for heart disease, 
including smoking, obesity, lack of exercise, diabetes, and use of postmenopausal hormone 
replacement therapy. The synthesis of CRP is under the regulatory control of IL-6. Although 
clinical and epidemiological studies are quite clear about the role of CRP as a predictive risk 
factor, the mechanism of action is still not elucidated. What is clear is that regimens such as 
dieting and exercise that have only modest effects on the known major risk factors, i.e., 
hypertension and dyslipidemia, have major effects on CRP. 
Inflammation may also, in part, explain the alcohol effect. Modest alcohol consumption, in 
the range of 1–2 drinks per day, lowers heart disease risk compared to complete abstinence. 
Alcohol consumption in the same range also lowers CRP [13]. Consuming lower glycemic 
index foods (foods digested or absorbed more slowly and that cause less of a rise in blood 
glucose and insulin) also lowers CRP [14]. Exercise is inversely associated with CRP [15] 
and weight loss reduces CRP [16]. A diet high in plant sterols, soy protein, viscous soluble 
fiber, and almonds has recently been shown to lower CRP by 28% [17]. 
 
5. Cardiac arrhythmias 
One of the most well established dietary effects in preventive cardiology is that of the 
protective effects of fish and fish oils on cardiac sudden death. The GISSI study found a 
decrease in sudden death (RR = 0.47) in the n-3 fatty acid-intervention group [18]. Several 
large prospective cohort studies have found similar results [19-21]. The findings from the 
Physicians Health Study are particularly dramatic with a 90% reduction in sudden death risk 
among those in the highest quartile of blood levels of long-chain n-3 fatty acid (Fig. 1) [19]. 
Although the n-3 fatty acids have numerous effects on pathways leading to atheromas and 
thrombosis, the largest impact may be on the heart itself [22]. In animal models of 
reperfusion, n-3 fatty acids reduce the severity of reperfusion-induced arrhythmia [23]. 
Purified long-chain n-3 fatty acids reduced fatal ventricular fibrillation in ischemic dogs [24]. 
These substances specifically inhibit the fast, voltage-dependent sodium entry current in 
 
 
 
 
 
Fig. 1. Relative risk of sudden death across quartiles of blood levels of long-chain n-3 fatty acids from the 
Physicians Health Study [16]. Numbers by bars are average percentages of n-3 fatty acids in blood of subjects. 
 
cardiac myocytes [25,26]. In human subjects, animal model, and cell culture experiments, 
these effects are observed at rather low concentrations, approximating those seen in people 
who consume moderate amounts of fatty fish [22]. 
 
6. Hemostasis 
Hemostasis is a complex mechanism with interacting activating cascades of biochemical 
factors. In a manner similar to the inflammatory process, hemostasis is a largely vascular 
process with numerous circulating agents. These can easily be measured in a peripheral blood 
sample but the correlation between these numerous biomarkers and CHD events is limited. 
Increased fibrinogen has been known for a long time as a cardiovascular risk factor [27]. 
Other newer hemostatic risk factors may include factor VIII, von Willebrand factor, fibrin D- 
dimer, and tissue plasminogen activator [28-30]. Three major pathways exist for the forming 
and dissolving of clots (Fig. 2). The coagulation cascade involves numerous protein factors 
and results in the conversion of fibrinogen to fibrin. The platelet activation pathway initiates 
the aggregation of platelets and their inclusion in the growing thrombus. The counter- 
balancing fibrinolytic pathway breaks down fibrin and slows nascent thrombus formation. 
Numerous dietary components have been shown to act on this complex system. The n-3 
fatty acids have been studied extensively and in model systems (usually at high doses) have a 
notable effect reducing platelet aggregation. Garlic, an important part of the Mediterranean 
diet, reduces platelet aggregation, increases fibrinolytic activity, and reduces fibrinogen 
concentration and resulting plasma viscosity [31,32]. Alcohol probably has its major effect on 
CHD through increasing HDL, but in human studies alcohol also reduces factor VIII and 
platelet aggregation and increases tissue plasminogen activator and bleeding time [33-36]. An 
intriguing recent study showed that modest beer consumption altered the secondary structure 
of fibrinogen, reducing its stability and its potential contribution to CHD risk [37]. Most 
hemostatic effects of alcoholic beverages do not seem to be beverage-specific. Although 
stearic acid, unlike other saturated fatty acids, has been shown to have little effect on 
cholesterol level, it has recently been shown to increase fibrinogen levels [38]. 
Lipoprotein (a) (LPA) is a known CHD risk factor. Although it is a variant of 
atherogenic  LDL,  probably  its  more  important  role  in  plaque  formation  is  due  to its 
 
 
 
 
 
 
Fig. 2. Simplified pathway of hemostasis. Positive and negative dietary modifiers of components and pathways are 
shown with gray arrows. MUFA = monounsaturated fatty acids. 
 
homology to plasminogen, which is largely responsible for the breakdown of fibrin clots. 
Plasminogen activation is blocked by LPA binding to fibrin and thus fibrinolysis is slowed 
[39]. The concentration of LPA is quite variable and is inversely correlated with the size of 
the apolipoprotein (a), which is under genetic control and hence the plasma concentration 
of LPA is not strongly affected by most dietary and environmental factors. There are 
several notable exceptions. Trans isomers of the monounsaturated fatty acid oleic acid may 
increase LPA substantially [40]. Fish oils have given variable effects generally in the 
protective direction [41]. 
Several classes of bioactive compounds found in plant foods are gaining increasing 
attention, in particular due to their antithrombotic effects. The flavonols, including quercetin, 
the catechins, and the epicatechins found in such diverse foods as apples, tea, cocoa, onions, 
and red wine, have been shown to lower platelet aggregation in vitro [42]. 
Compared to other energy sources such as saturated fatty acids and carbohydrates, 
monounsaturated fatty acids, such as those found in olive oil, have multiple protective effects 
on hemostasis. These include a lowering of platelet aggregation, lowering plasma levels of 
von Willebrand factor and factor VII and increasing fibrinolysis [43]. 
 
7. Endothelial function 
In a sense, endothelial dysfunction is where all the risk factors meet. The initial prooxidant, 
inflammatory, dyslipidemic, and thrombotic effects meet in the deterioration of the vascular 
endothelium and the establishment of unstable plaques. For the purposes of this review, we 
will focus on a common functional test of endothelial function, flow-mediated vasodilation 
(FMV). Nitric oxide is the primary modulator of smooth muscle relaxation and vasodilation 
 
 
and induces FMV. Dietary elements that reduce nitric oxide synthesis reduce FMV and lead to 
deteriorating endothelial function. 
A daily glass of red wine ameliorates the tendency of a high fat diet to decrease FMV [44]. 
A fruit and vegetable juice concentrate has a similar effect [45]. Other phytochemicals appear 
to increase FMV, including soy isoflavones [46], especially genistein [47]. 
Dietary fatty acids have varying effects on FMV. A 4-week replacement of saturated fatty 
acids by trans fatty acids saw a significant decrease of FMV as well as a significant decrease 
in HDL [48]. Conversely, both the n-3 fatty acids and the MUFAs lead to an increase in FMV 
[49,50]. Weight loss and exercise both improve FMV [51,52]. 
Homocysteine (HCY) is a byproduct of insufficient methyl group metabolism. In the 
1960s McCully initially identified the role of homocysteinemia in the pathogenesis of 
atherosclerosis [53]. Three B vitamins, namely, B6, B12, and especially folate, are 
instrumental in homocysteine metabolism (Fig. 3). HCY is detrimental to the endothelium, 
reducing the availability of nitric oxide, decreasing FMV, increasing intima-media thickening, 
and increasing arterial wall thickening [54,55]. HCY has been found to be higher in smokers 
and men and is positively associated with hard liquor intake and advancing age. Generally, 
the treatment of high HCY is straightforward: the administration of folate, vitamin B12, and 
vitamin B6, either in foods (particularly the leafy green vegetables) or as modest supplements. 
The 677C N T genotype of methylenetetrahydrofolate reductase also causes high serum HCY 
levels and can be treated with high daily doses of folate [56]. As a risk factor for CHD in the 
United  States,  the  effect  of  hyperhomocysteinemia  may  be  declining  because  of  the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Pathways of homocysteine and sulfur amino acid metabolism. B vitamins involved in enzymatic steps are 
indicated by arrows. CH2 = methylene; CH3 = methyl; THF = tetrahydrofolate. 
 
 
fortification of grains with folate since the mid 1990s. In one study the blood level of folate 
increased 38% since fortification [57]. 
 
8. Conclusion 
Numerous observational and clinical studies have confirmed the effects of nutrients and 
other dietary elements on CHD that operate through pathways other than lowering LDL and 
triglyceride, raising HDL, or lowering blood pressure. Since dietary choices are based on 
foods and not specific nutrients, effective recommendations to prevent CHD need to be based 
on beneficial foods and dietary patterns. A constellation of healthy food choices for vascular 
health appears together in the various traditional diets of the Mediterranean countries. Based 
on the reviewed literature, the common beneficial components of these diets include olive oil 
with its MUFA, regular moderate wine consumption with meals, garlic use, copious fresh 
fruits and vegetables, low intake of red meat and saturated fat, increased fish consumption, 
and low glycemic index staple foods. The Lyon Diet Heart Study used this diet (with the 
addition of a-linolenic acid) to reduce recurring heart disease by 72% without lowering blood 
pressure, LDL cholesterol, and triglycerides, or raising HDL cholesterol. 
In addition, nontraditional risk factors can be actively improved by more traditional 
recommendations, including maintaining a healthy body weight (BMI b 25), smoking 
cessation, and regular exercise. The regular consumption of fatty fish has clear 
cardioprotective effects. The addition of rather large amounts of trans fatty acids to the 
Western diet in recent decades is proving deleterious, and the pathways of the effects are 
being elucidated. HCY and its effects on the vascular endothelium can be easily controlled 
through a diet rich in dark green leafy vegetables and possibly a supplement of B vitamins at 
the modest levels found in most multivitamin pills. 
Determining the physiological mode of action of these dietary elements is difficult. In 
addition, identifying the active components of the foods we consume is also a continuing 
challenge, particularly when considering the phytochemicals in the beneficial fruits and 
vegetables. Although the mechanisms of action of these dietary components are still being 
explored and much is not yet known, recommendations should not be withheld in regard to 
known foods and dietary patterns that may drastically lower CHD risk. 
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